Virax Biolabs

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

Data from AbbVie and Johnson & Johnson will fine-tune OpenFold3 in a confidentiality-preserving environment, powered by Apheris.

Another company involved in using AI to repurpose failed drugs - as well as drugs that have already been approved - is BioXcel Therapeutics. Unlike Ignota, however, the company focuses on compounds that have already demonstrated safety in prior clinical trials, but have been discontinued by their developers for various other reasons.

Telescope Innovations Corp. (CSE:TELI) is leveraging its expertise to advance chemistry process development and crystallization optimization in pharmaceuticals, industrial chemicals, and critical minerals ・Telescope's Self-Driving Labs (SDLs) integrate AI,

James Foster, CEO and co-founder of Virax Biolabs, discusses how AI and machine-learning algorithms are changing the ways that companies approach their launch strategies.

Oxipital AI today announced that it will showcase its AI vision solutions at the International Processing and Production Expo (IPPE) in booth B49003. The show will be held from January 28 to January 30,

Sridevi Palepu's work redefines the landscape of immuno-hematology with advanced robotics, AI-driven precision, and user-focused design.

Wen Shuhao helped speed up the development of Pfizer's Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help make better solar panels and EV batteries.